title: Cost-effectiveness analyses of treatments for multiple sclerosis: are they clinically relevant?
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: Smyth
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods; D017048:Health Care Costs; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000191:economics*; D017063:Outcome Assessment, Health Care / Q000379:methods*
chemical_list: D007166:Immunosuppressive Agents